Ohio State

Croce Out as Chair

Retraction Watch reports Ohio State has pushed Carlo Croce to step down as department chair.

Mostly Dismissed

Retraction Watch reports that a judge dismissed most of the lawsuit Ohio State University's Carlo Croce brought against the New York Times.

Patients whose tumors had methylated MGMT promoters were more likely to survive than those that did not after combination treatment with radiotherapy and temozolomide.

Science reports that Ohio State University cancer researcher Ching-Shih Chen resigned due to misconduct findings.

Prospective panel sequencing on colorectal cancer patients picked up Lynch syndrome with sensitivity and specificity that met or exceeded gene-by-gene tests.

The researchers plan to add the MSI detection capabilities to an NGS panel and will use the information to guide cancer patients to precision medicine trials.

Croce's Suit

Ohio State's Carlo Croce sues the New York Times over its article on research misconduct allegations, Retraction Watch reports.

This Week in Science

In Science this week: genomic investigation of maize's adaption to temperate climates, and more.

Concerns Issued

Retraction Watch reports that PNAS has issued expressions of concern about two papers from Ohio State's Carlo Croce.

Pages

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.